Medication info
Ciprofloxacin Tablet 250mg (Ciprofloxacin Hydrochloride)

Ciprofloxacin Tablet 250mg (Ciprofloxacin Hydrochloride)

Prescription medicationTabletOral
Ingredient · strength
Ciprofloxacin Hydrochloride›291mg / 1 tablet
Manufacturer / importer
Vivozon Pharmaceutical Co., Ltd.
Appearance
White to pale yellow round film-coated tablets
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Active

MFDS item code 200401235 · Notified 2004.07.08 · Insurance code 658200640

Summary

Main use
Treatment of bacterial infections (e.g., urinary tract, respiratory, and skin infections)
Who takes it
Adults
Adult dose
○ The usual adult dose is ciprofloxacin 250 ~ 500 mg per dose orally twice daily between meals. For severe complicated infections, the dose may be increased to 750 mg per dose twice daily. For acute infections, treatment is usually given for 5 ~ 10 days, and continued for at least 3 days after symptoms disappear. ○ Patients with renal impairment 1) Creatinine clearance > 50 mL/min: Administer the usual dose. 2) 30 ~ 50 mL/mn: Administer 250 ~ 500 mg per dose twice daily. 3) 5 ~ 29 mL/min: Administer 250 ~ 500 mg every 18 hours. 4) Patients undergoing hemodialysis or peritoneal dialysis: Administer 250 ~ 500 mg per dose once daily after dialysis. 5) If only serum creatinine is known, creatinine clearance can be calculated using the following formula. Men: {body weight (kg) × (140-age)}/ {72 × serum creatinine (mg/dL)} Women: 0.85 × the value calculated for men 6) For severe infections, the dose per administration may be increased to 750 mg even in patients with severe renal impairment; however, the patient's condition should be monitored closely after administration. Adjust the dose as appropriate according to symptoms.

Ingredients

Manufacturer
Vivozon Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of bacterial infections (e.g., urinary tract, respiratory, and skin infections)

  • Acute bronchitis
  • respiratory infections
  • community-acquired pneumonia
  • pharyngitis
  • tonsillitis
  • laryngitis
  • otitis externa
  • chronic cholesteatomatous otitis media
  • chronic otitis media
  • bacterial prostatitis
  • acute uncomplicated cystitis
  • acute pyelonephritis
View approved original text

This medicine is used for the treatment of various infections caused by bacteria such as Escherichia coli, Salmonella, and Staphylococcus. It is effective against respiratory infections, except for acute bronchitis, and community-acquired pneumonia, and is also applicable to ear, nose, and throat infections. Furthermore, it is used to treat various infections including bacterial prostatitis, urinary tract infections, gastrointestinal infections, bile duct infections, skin and soft tissue infections, and bone and joint infections. It is also prescribed for gynecological infections, peritonitis, and fistulitis, and should be used cautiously when there are concerns regarding serious adverse reactions as a fluoroquinolone antibiotic, particularly in situations where no other treatment options are available. This drug is used effectively to treat various bacterial infections.

How to take

Adult dose

○ The usual adult dose is ciprofloxacin 250 ~ 500 mg per dose orally twice daily between meals. For severe complicated infections, the dose may be increased to 750 mg per dose twice daily. For acute infections, treatment is usually given for 5 ~ 10 days, and continued for at least 3 days after symptoms disappear. ○ Patients with renal impairment 1) Creatinine clearance > 50 mL/min: Administer the usual dose. 2) 30 ~ 50 mL/mn: Administer 250 ~ 500 mg per dose twice daily. 3) 5 ~ 29 mL/min: Administer 250 ~ 500 mg every 18 hours. 4) Patients undergoing hemodialysis or peritoneal dialysis: Administer 250 ~ 500 mg per dose once daily after dialysis. 5) If only serum creatinine is known, creatinine clearance can be calculated using the following formula. Men: {body weight (kg) × (140-age)}/ {72 × serum creatinine (mg/dL)} Women: 0.85 × the value calculated for men 6) For severe infections, the dose per administration may be increased to 750 mg even in patients with severe renal impairment; however, the patient's condition should be monitored closely after administration. Adjust the dose as appropriate according to symptoms.

Precautions

This drug may cause serious side effects such as tendinitis or tendon rupture; therefore, if such symptoms occur, it should be discontinued immediately. Particularly in patients with myasthenia gravis, using this drug may worsen symptoms, so it should not be administered. Pregnant women or women who may become pregnant, breastfeeding women, children and adolescents under 18 years of age, and patients with epilepsy should not use this drug. Moreover, co-administration with certain medications (e.g., tizanidine, ketoprofen) may increase the risk of side effects, so they should be avoided. Elderly patients or those with severely impaired renal function, or patients with a history of seizures should use this drug cautiously and be closely monitored. This medication can affect the central nervous system, leading to dizziness, seizures, and mental confusion, necessitating caution. During treatment, care should be taken to avoid strong sunlight or artificial ultraviolet exposure; if skin rash or itching occurs, use should be immediately stopped. Diabetic patients with poor blood sugar control should closely monitor blood sugar changes, and if hypoglycemic symptoms appear, immediate treatment should be conducted. Additionally, this medication can interact with various drugs; therefore, if other medications are taken, it is essential to inform healthcare professionals. If neurological symptoms such as pain, sensory disturbances, or changes in vision occur during treatment, consult a specialist immediately. Overdose may affect kidney function; thus, in emergencies, proper care should be received promptly. This drug should be stored out of reach of children and protected from direct sunlight or ultraviolet light.

Side effects

Tendinitis, tendon rupture, peripheral neuropathy, central nervous system effects, exacerbation of myasthenia gravis, fungal superinfection, antibiotic-associated colitis, eosinophilia, thrombophlebitis, leukopenia, anemia, neutropenia, leukocytosis, thrombocytopenia, thrombocytosis, reduced red blood cells, decreased hemoglobin, decreased hematocrit, granulocyte reduction, leukolysis, hemolytic anemia, agranulocytosis, pancytopenia, bone marrow suppression, increased INR value, inappropriate secretion of antidiuretic hormone syndrome, allergic reactions, allergic edema, angioedema, anaphylactic reactions, anaphylactoid shock, serum sickness-like reactions, decreased appetite, reduced food intake, increased serum alkaline phosphatase, hyperglycemia, hypoglycemia, increased lipase, abnormal prothrombin levels, increased amylase, psychomotor agitation, anxiety, confusion, disorientation, emotional instability, abnormal dreams, depression, hallucinations, psychotic reactions, toxic psychosis, headache, dizziness, sleep disorders, taste disorders, insomnia, sensory disturbances, reduced sensation, loss of taste, tremors, convulsions, vertigo, mental confusion, seizures, drowsiness, migraine, coordination disorders, olfactory disorders, anosmia, sensory hyperesthesia, increased intracranial pressure, coordination deficits, peripheral neuropathy, polyneuropathy, visual disturbances, color vision disturbances, double vision, tinnitus, hearing loss, transient hearing loss, hearing impairment, tachycardia, vasodilation, hypotension, syncope, vasculitis, QT prolongation, ventricular tachycardia, Torsades de Pointes, dyspnea, laryngeal edema, nausea, diarrhea, anorexia, gastric discomfort, vomiting, gastrointestinal and abdominal pain, abdominal distension, dyspepsia, pseudomembranous colitis, stomatitis, oral candidiasis, gastrointestinal candidiasis, pancreatitis, abnormal liver function tests, increased bilirubin, liver dysfunction, jaundice, hepatitis, cholestatic jaundice, liver necrosis, rash, itching, urticaria, photosensitivity, vesicles, petechiae, erythema multiforme, fixed drug eruption, acute generalized exanthematous pustulosis, arthralgia, musculoskeletal pain, myalgia, arthritis, increased muscle tension and cramps, joint swelling, myasthenia, muscle weakness, partial or complete tendon rupture, renal impairment, hematuria, crystalluria, interstitial nephritis, vaginal candidiasis, undiagnosed pain, discomfort, fever, asthenia, edema, sweating, gait disturbances, maculopapular rash, purpuric rash, acute generalized exanthematous pustulosis, aneurysm, aortic dissection, valvular regurgitation, valvular insufficiency, shock, hypotension, chest tightness, muscle weakness, rhabdomyolysis, cough, abnormal chest X-ray, eosinophilia, interstitial pneumonia, visual impairment

Not everyone experiences these, and they can vary from person to person.

Storage

This drug should be stored in a tightly closed container to protect it from air and moisture, and the storage temperature should be maintained between 1 and 30 degrees Celsius at room temperature. Storing in this manner will help to maintain the drug's efficacy for a longer time.

Appearance and packaging

Appearance

White to pale yellow round film-coated tablets

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.